Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Hollander

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Plastic and Reconstructive Surgery. Global Open|February 26, 2026
Balanced Restoration: Optimizing Midface Rejuvenation Using Hyaluronic Acid FillersRod J Rohrich, Raul Cetto, Conor J Gallagher, et al.
Advances in Therapy|February 25, 2021
Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular HypertensionMakoto Araie, Kazuhisa Sugiyama, Kenji Aso, et al.
Current Medical Research and Opinion|May 30, 2009
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapyDonald R Nixon, David B Yan, Jean-Pierre Chartrand, et al.
Cornea|September 15, 2022
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye DiseaseDavid Wirta, Gail L Torkildsen, Blair Boehmer, et al.
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Advances in Therapy|August 21, 2023
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)Makoto Araie, Kazuhisa Sugiyama, Kenji Aso, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 3, 2011
Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authorsJoan-En Chang-Lin, Amy L Batoosingh, David A Hollander, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
BMC Ophthalmology|December 30, 2017
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eyePeter J McDonnell, Stephen C Pflugfelder, Michael E Stern, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Plastic and Reconstructive Surgery. Global Open|February 26, 2026
Balanced Restoration: Optimizing Midface Rejuvenation Using Hyaluronic Acid FillersRod J Rohrich, Raul Cetto, Conor J Gallagher, et al.
Advances in Therapy|February 25, 2021
Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular HypertensionMakoto Araie, Kazuhisa Sugiyama, Kenji Aso, et al.
Current Medical Research and Opinion|May 30, 2009
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapyDonald R Nixon, David B Yan, Jean-Pierre Chartrand, et al.
Cornea|September 15, 2022
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye DiseaseDavid Wirta, Gail L Torkildsen, Blair Boehmer, et al.
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Advances in Therapy|August 21, 2023
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)Makoto Araie, Kazuhisa Sugiyama, Kenji Aso, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 3, 2011
Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authorsJoan-En Chang-Lin, Amy L Batoosingh, David A Hollander, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
BMC Ophthalmology|December 30, 2017
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eyePeter J McDonnell, Stephen C Pflugfelder, Michael E Stern, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Pageof 8